Biotechnology company that develops a gene therapy with a multifactorial approach against Alzheimer's disease and other neurodegenerative diseases
Tetraneuron has raised €9.9M across 2 funding rounds from 1 investor, most recently a round in Jan 2026. Based in Valencia, Spain; active in Healthtech. Data as of 8 Aug 2026.
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-01-21 | Other | €4.9M | GIMIC Ventures | View deal → |
| 2022-12-27 | Other | €5.0M | — | View deal → |
